QLS1128 A-Dose 1~5 and Ritonavir
QLS1128-101
Phase 1 small_molecule active
Quick answer
QLS1128 A-Dose 1~5 and Ritonavir for COVID-19 is a Phase 1 program (small_molecule) at Qilu Pharmaceutical (Hainan) Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Qilu Pharmaceutical (Hainan) Co.,
- Indication
- COVID-19
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active